Taysha Gene Therapies to Release Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 8GlobeNewsWire • 11/02/22
Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma's Strategic Investment to Support the Development of Taysha's AAV-based Gene Therapy ProgramsGlobeNewsWire • 10/24/22
Astellas and Taysha Gene Therapies Announce Strategic Investment to Support Development of Taysha's AAV-based Gene Therapy ProgramsPRNewsWire • 10/24/22
Taysha Gene Therapies Announces Presentations at the Upcoming 29th Annual Meeting of the European Society of Gene & Cell Therapy (ESGCT)GlobeNewsWire • 10/06/22
Taysha Gene Therapies, Inc. (TSHA) CEO RA Session on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/13/22
Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 08/11/22
Taysha Gene Therapies to Release Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11GlobeNewsWire • 08/09/22
Taysha Gene Therapies to Participate in Upcoming William Blair Biotech Focus Conference 2022GlobeNewsWire • 07/06/22
Taysha Gene Therapies to Participate in Upcoming June Investor Conferences and ConventionGlobeNewsWire • 06/02/22
Taysha Gene Therapies, Inc. (TSHA) CEO RA Session II on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/16/22
Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/16/22
Taysha Gene Therapies to Release First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 16GlobeNewsWire • 05/11/22
Taysha Gene Therapies Announces Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell TherapyGlobeNewsWire • 05/10/22
Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-120 for the Treatment of Giant Axon Neuropathy (GAN)GlobeNewsWire • 05/03/22
Taysha Gene Therapies Announces Oral Presentations at the Upcoming 2022 IRSF Rett Syndrome Scientific Symposium and the ASCEND National SummitGlobeNewsWire • 04/25/22
Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell Therapy Manufacturing SummitGlobeNewsWire • 04/18/22
Wall Street Analysts Believe Taysha Gene Therapies, Inc. (TSHA) Could Rally 608%: Here's is How to TradeZacks Investment Research • 04/04/22
Taysha Gene Therapies (TSHA) CEO RA Session II on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/31/22